Get my own profile
Public access
View all5 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Danny Reinberg, Ph.D.Principal Investigator, Prof. of Biochemistry, HHMI/NYU Langone School of Med.Verified email at nyumc.org
- Roberto BonasioAssociate Professor, University of PennsylvaniaVerified email at pennmedicine.upenn.edu
- David BeckAssistant Professor, New York UniversityVerified email at nyulangone.org
- Esteban A. EngelDirector, Neuroscience Platform Technologies - Spark TherapeuticsVerified email at sparktx.com
- Pablo ValenzuelaScientific Director, Fundación Ciencia & VidaVerified email at cienciavida.org
- Diego CadavidUniversity of Massachusetts Medical SchoolVerified email at umassmemorial.org
- Ning ShenZhejiang UniversityVerified email at zju.edu.cn
- Matthias StadtfeldWeill Cornell MedicineVerified email at med.cornell.edu
- Varun NarendraNew York UniversityVerified email at nyumc.org
- Ben GarciaAssociate Professor, University of Pennsylvania School of MedicineVerified email at mail.med.upenn.edu
- Simon VidalRetro BiosciencesVerified email at retro.bio
- Masashi YamajiTakeda Pharmaceutical CompanyVerified email at takeda.com
- Oscar Fernandez-CapetilloGenomic Instability Group, Spanish National Cancer Research Centre (CNIO)Verified email at cnio.es
- Amber Mueller, PhDPostdoctoral Fellow, Harvard Medical SchoolVerified email at hms.harvard.edu
- Gary LeRoyNYU School of MedicineVerified email at nyumc.org
Follow
Luis Alejandro Rojas
Director, Lead Generation at Ananke Therapeutics
Verified email at ananketx.com